136 related articles for article (PubMed ID: 1593490)
1. Increased production of tumour necrosis factor by peripheral blood leukocytes in patients with recurrent oral aphthous ulceration.
Taylor LJ; Bagg J; Walker DM; Peters TJ
J Oral Pathol Med; 1992 Jan; 21(1):21-5. PubMed ID: 1593490
[TBL] [Abstract][Full Text] [Related]
2. The in vitro cytotoxic effect of leukocytes from patients with recurrent aphthous ulceration upon mouse 3T3 fibroblasts.
Thomas DW; Bagg J; Walker DM
J Oral Pathol; 1988 Sep; 17(8):421-5. PubMed ID: 3146629
[TBL] [Abstract][Full Text] [Related]
3. Immunolocalization of tumor necrosis factor-alpha expressing cells in recurrent aphthous ulcer lesions (RAU).
Natah SS; Häyrinen-Immonen R; Hietanen J; Malmström M; Konttinen YT
J Oral Pathol Med; 2000 Jan; 29(1):19-25. PubMed ID: 10678712
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor activity in recurrent aphthous ulceration.
Borra RC; de Mesquita Barros F; de Andrade Lotufo M; Villanova FE; Andrade PM
J Oral Pathol Med; 2009 Mar; 38(3):289-98. PubMed ID: 19267841
[TBL] [Abstract][Full Text] [Related]
5. Levamisole can modulate the serum tumor necrosis factor-alpha level in patients with recurrent aphthous ulcerations.
Sun A; Wang JT; Chia JS; Chiang CP
J Oral Pathol Med; 2006 Feb; 35(2):111-6. PubMed ID: 16430742
[TBL] [Abstract][Full Text] [Related]
6. Salivary interleukin-6 and tumor necrosis factor-alpha in patients with recurrent aphthous ulceration.
Boras VV; Lukac J; Brailo V; Picek P; Kordić D; Zilić IA
J Oral Pathol Med; 2006 Apr; 35(4):241-3. PubMed ID: 16519772
[TBL] [Abstract][Full Text] [Related]
7. A clinical trial of Azelastine in recurrent aphthous ulceration, with an analysis of its actions on leukocytes.
Ueta E; Osaki T; Yoneda K; Yamamoto T; Kato I
J Oral Pathol Med; 1994 Mar; 23(3):123-9. PubMed ID: 8021845
[TBL] [Abstract][Full Text] [Related]
8. T-lymphocyte subsets in recurrent aphthous ulceration.
Pedersen A; Klausen B; Hougen HP; Stenvang JP
J Oral Pathol Med; 1989 Jan; 18(1):59-60. PubMed ID: 2526218
[TBL] [Abstract][Full Text] [Related]
9. Innate immune system is implicated in recurrent aphthous ulcer pathogenesis.
Lewkowicz N; Lewkowicz P; Kurnatowska A; Banasik M; Glowacka E; Cedzyński M; Swierzko A; Lauk-Puchala B; Tchórzewski H
J Oral Pathol Med; 2003 Sep; 32(8):475-81. PubMed ID: 12901729
[TBL] [Abstract][Full Text] [Related]
10. Predominance of Type 1 cytokines and decreased number of CD4(+)CD25(+high) T regulatory cells in peripheral blood of patients with recurrent aphthous ulcerations.
Lewkowicz N; Lewkowicz P; Banasik M; Kurnatowska A; Tchórzewski H
Immunol Lett; 2005 Jun; 99(1):57-62. PubMed ID: 15894112
[TBL] [Abstract][Full Text] [Related]
11. IL-17C and its receptor IL-17RA/IL-17RE identify human oral epithelial cell as an inflammatory cell in recurrent aphthous ulcer.
Al-Samadi A; Kouri VP; Salem A; Ainola M; Kaivosoja E; Barreto G; Konttinen YT; Hietanen J; Häyrinen-Immonen R
J Oral Pathol Med; 2014 Feb; 43(2):117-24. PubMed ID: 23834281
[TBL] [Abstract][Full Text] [Related]
12. Increased beta 2 defensin in recurrent aphthous ulcer.
Al-Samadi A; Salem A; Ainola M; Hietanen J; Häyrinen-Immonen R; Konttinen YT
Oral Dis; 2015 Apr; 21(3):292-8. PubMed ID: 24854020
[TBL] [Abstract][Full Text] [Related]
13. Natural immunity in recurrent aphthous ulceration.
Sistig S; Cekic-Arambasin A; Rabatic S; Vucicevic-Boras V; Kleinheinz J; Piffko J
J Oral Pathol Med; 2001 May; 30(5):275-80. PubMed ID: 11334463
[TBL] [Abstract][Full Text] [Related]
14. Oral ulceration in HIV infection: investigation and pathogenesis.
MacPhail LA; Greenspan JS
Oral Dis; 1997 May; 3 Suppl 1():S190-3. PubMed ID: 9456687
[TBL] [Abstract][Full Text] [Related]
15. Salivary levels of vascular endothelial growth factor (VEGF) in recurrent aphthous ulceration.
Brozovic S; Vucicevic-Boras V; Mravak-Stipetic M; Jukic S; Kleinheinz J; Lukac J
J Oral Pathol Med; 2002 Feb; 31(2):106-8. PubMed ID: 11896832
[TBL] [Abstract][Full Text] [Related]
16. Oral mucosal antigen reactivity during exacerbation and remission phases of recurrent aphthous ulceration.
Lindemann RA; Riviere GR; Sapp JP
Oral Surg Oral Med Oral Pathol; 1985 Sep; 60(3):281-4. PubMed ID: 3862041
[TBL] [Abstract][Full Text] [Related]
17. Evaluating and comparing phagocytic functions of salivary and blood neutrophils in patients with recurrent aphthous ulcers and controls.
Kumar BP; Keluskar V; Bagewadi AS; Shetti A
Quintessence Int; 2010 May; 41(5):411-6. PubMed ID: 20376377
[TBL] [Abstract][Full Text] [Related]
18. "Tien-Hsien liquid" can modulate antigen-stimulated cytokine production by T-cells isolated from patients with recurrent aphthous ulcerations.
Sun A; Chia JS; Wang WB; Chiang CP
Am J Chin Med; 2005; 33(4):559-71. PubMed ID: 16173530
[TBL] [Abstract][Full Text] [Related]
19. Peripheral lymphocyte subpopulations in recurrent aphthous ulceration.
Pedersen A; Klausen B; Hougen HP; Ryder LP
Acta Odontol Scand; 1991 Aug; 49(4):203-6. PubMed ID: 1681668
[TBL] [Abstract][Full Text] [Related]
20. Increased density of lymphocytes bearing gamma/delta T-cell receptors in recurrent aphthous ulceration (RAU).
Natah SS; Häyrinen-Immonen R; Hietanen J; Patinen P; Malmström M; Savilahti E; Konttinen YT
Int J Oral Maxillofac Surg; 2000 Oct; 29(5):375-80. PubMed ID: 11071244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
